National University Polyclinics, Singapore
9
1
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Frailty Improvement Through Technology With Informal Caregiver Supported Exercise (FITWISE) for Pre-frail and Frail Community-dwelling Older Adults
Role: collaborator
Artificial Intelligence (AI) - Assisted Visual Impairment Screening Model: Community-based Implementation and Evaluation of Performance, Feasibility and Costs.
Role: collaborator
Intensive Aerobic and Resistance Exercise Program (IAREP)
Role: collaborator
AdLip: Human Coach-supported Digital/AI Personal Health Assistant to Improve Adherence to Lipid-Lowering Medication
Role: collaborator
A Health Education Intervention Tailored for Malay-Muslim Women
Role: collaborator
Doctor's Counselling Using Culturally-responsive Pamphlet Increased Mammogram Uptake Among Malay-Muslim Women in Singapore
Role: lead
GLucose Monitoring Programme SingaporE, Phase 2 (GLiMPSE2)
Role: collaborator
A Mobile Health-enabled Lifestyle Intervention Among Women With History of Gestational Diabetes(GDM)
Role: collaborator
Ectopic Fat in Singaporean Women - the Culprit Leading to Gestational Diabetes, Metabolic Syndrome, and Type 2 Diabetes (TANGO Study)
Role: collaborator
All 9 trials loaded